The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the dose of roflumilast to be used for asthma
management by comparing the effects of 250 mcg and 500 mcg oral roflumilast with placebo on
pulmonary function and asthma symptoms.